You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

You’ve been redirected to the new Cancer Care Ontario website. You can also visit the archived website, which is no longer being maintained.

Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation

ID: 4-5 Jun 2016
Type of Content: Guidelines & Advice, Clinical
Document Status: In-Review
Authors:
H. Lukka, H. Hirte, A. Fyles, G. Thomas, M. Fung Kee Fung, M. Johnston , Gynecology Cancer Disease Site Group

Patient Population

Women with cervical cancer for whom primary treatment with radiotherapy is being considered:

  • Those with locally advanced cervical cancer
  • Those with bulky clinical stage IB (>4 cm) cervical cancer, who are treated with radiotherapy
  • Those with high-risk early-stage cervical cancer (node-positive or margin-positive), who will be treated with radiotherapy following hysterectomy

Research Question(s)

For women with cervical cancer in whom radiotherapy is considered appropriate, does the addition of concurrent platinum-based chemotherapy improve survival and quality of life with acceptable toxicity?

pdf download Summary (PDF) (311.01 KB)
pdf download Full Report (PDF) (937.66 KB)